News Category
PolyPeptide shareholders approved a new board and removed takeover defenses, clearing the path for Samsung Biologics' tender offer and signaling a maj...
The UK's MHRA has issued new safety measures for antidepressants, including warnings about suicide risk for all ages and persistent sexual dysfunction...
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its MindWave Innovations subsidiary will list the NILA token on the Pionex excha...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies to reduce animal testing, accelerate clinical advancement, and cu...
Peptide Wholesale Supply now applies HPLC testing to every batch of BPC-157, Semaglutide, and Tirzepatide in bulk orders, providing researchers with d...
Telomir Pharmaceuticals' Telomir-Zn inhibits osteosarcoma growth in human and canine cell lines, opening a potential dual veterinary-human development...
Kairos Pharma's CEO will present at the H.C. Wainwright conference, underscoring the company's progress in overcoming cancer drug resistance with its ...
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial highlights a novel approach to MS that could protect and repair myelin, not just suppress...
Nutriband received a USPTO Notice of Publication for trademarks linked to its abuse-deterrent fentanyl patch, a step toward commercializing a product ...
Quantum BioPharma's Lucid-MS candidate for progressive multiple sclerosis draws a 'Buy' rating from Rodman & Renshaw with an $8 price target, highligh...
Earth Science Tech's acquisition of Zoolzy LLC enhances profit margins, broadens ingredient access, and opens the veterinary market, reinforcing its t...
Italian pharmaceutical company DuLac Farmaceutici is broadening its U.S. market presence by launching products on OneLavi and preparing for key retail...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate program past the discovery phase, signaling progress in its oncology pipeli...
Onco-Innovations' LOI with Ifowonco could expand its immuno-oncology pipeline, potentially enhancing solid tumor treatments by combining DDR inhibitio...
Earth Science Tech's acquisition of Zoolzy LLC is set to enhance its pharmaceutical supply chain, improve profit margins, and open new opportunities i...
SCHOTT Pharma's parent group's updated climate targets, including a new absolute Scope 3 emissions reduction goal, have been validated by the SBTi, st...
Helus Pharma's completion of enrollment in its pivotal Phase 3 trial for HLP003 marks a significant step toward a potential new treatment for major de...
VERAXA Biotech's VXA-222 bispecific ADC program has moved past discovery, and the company has strengthened its IP with new patent filings, underscorin...
Tonix Pharmaceuticals received FDA feedback supporting its Phase 2 study of TNX-4800, a long-acting monoclonal antibody for Lyme disease prevention, m...
VERAXA Biotech announces a key technical milestone in its collaboration with OmniAb, advancing the bispecific ADC program VXA-222 to the next phase, p...
VERAXA Biotech AG appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor therapies, signaling a strategic push towa...
NanoViricides announced a $3.8 million registered direct offering with a fundamental institutional investor to fund its broad-spectrum antiviral drug ...
VERAXA Biotech appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, leveraging his two decades ...
VERAXA Biotech AG obtained Scientific Advice from Germany's Paul-Ehrlich-Institute, supporting its development strategy for the lead BiTAC(R)-TCE cand...
VERAXA Biotech AG has received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, providing clarity on development st...
Siegfried has appointed Eduardo Montanha as COO to lead its integrated global operations, supporting the company's strategy of offering end-to-end sol...
NextPlat Corp's agreement to acquire a Florida pharmacy for $1.5 million expands its PharmcoRx retail footprint into an underserved rural market, supp...
Onco-Innovations Limited has completed an analytical reference standard program for its lead oncology candidate ONC010, strengthening its CMC framewor...
VERAXA Biotech has begun cell line development for its lead BiTAC T-cell engager, partnering with ATUM to advance toward IND/CTA-enabling studies, mar...
The sustained release polymers market is projected to grow from USD 3.8 billion in 2026 to USD 7.8 billion by 2036, driven by rising chronic diseases,...
VERAXA Biotech AG reported progress in its BiTAC platform and partnering strategy, with four BiTAC-based T-cell engager programs targeting solid tumor...
VERAXA Biotech has begun cell line development for its lead BiTAC T-cell engager program, aiming to improve tumor selectivity and reduce off-tumor tox...
The antibody therapeutics sector, particularly antibody-drug conjugates and T-cell engagers, continues to see strong deal activity, highlighting the p...
Ace Therapeutics announces a full-spectrum preclinical analgesic drug development platform with over 20 validated pain models, aiming to accelerate pa...
Medios AG is closing its Aschaffenburg facility and consolidating patient-specific manufacturing across its German network to counter sustained margin...
Helus Pharma announced fiscal 2026 financial results and progress on its Phase 3 trial for HLP003 in major depressive disorder, with topline data expe...
Voyageur Pharmaceuticals has hired Fluor Corporation to conduct feasibility studies for an iodine extraction facility in Oklahoma and an integrated dr...
Knight Therapeutics Inc. has repaid all outstanding amounts under its revolving credit facility, demonstrating strong cash flow and financial stabilit...
Voyageur Pharmaceuticals is evaluating three U.S. sites for a vertically integrated contrast media manufacturing facility, aiming to reduce costs and ...
Earth Science Tech Inc. has completed a vertically integrated telehealth and pharmacy ecosystem, positioning itself at the intersection of telemedicin...
Voyageur Pharmaceuticals announces submission of a five-year exploration permit for its Frances Creek barite project, including a 2,000-tonne test ext...
Voyageur Pharmaceuticals closed a non-brokered private placement raising $5 million to fund FDA licensing for its barium contrast products and develop...
Kairos Pharma announced plans to acquire worldwide rights to CL-741, a Phase 1-ready oral c-MET kinase inhibitor, and provided updates on its clinical...
Quantum BioPharma Ltd. discussed its lead drug candidate Lucid-MS for multiple sclerosis and its commercial product unbuzzd for alcohol metabolism, em...
Quantum BioPharma's clinical-stage multiple sclerosis program targeting demyelination and its diversified portfolio spanning therapeutics and consumer...
Redwood AI Corp. announces DTC eligibility for its common shares to simplify U.S. trading and enhance liquidity, and hires IBN for a $114,000 investor...
Carmed Pharmaceuticals, a Turkey-based company specializing in carvacrol-based formulations, expands into the U.S. market through a CityBiz executive ...
Sino Biological's new XPressMAX™ kit enables ultra-fast, high-success protein synthesis in 3 hours, integrating with AI-driven high-throughput screeni...
